Melanoma survival: Sex does matter, but we do not know how

European Journal of Cancer Prevention

Volumn 25, Issue 5, 2016, Pages 404-409

  Crocetti, Emanuele ^a   Fancelli, Laura ^a   Manneschi, Gianfranco ^a   Caldarella, Adele ^a   Pimpinelli, Nicola ^a   Chiarugi, Alessandra ^a   Nardini, Paolo ^a   Buzzoni, Carlotta ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Melanoma; Population based; Sex; Survival

Indexed keywords

ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; DEMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; MIDDLE AGED; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN ULCER; COMPARATIVE STUDY; FOLLOW UP; ITALY; MORTALITY; PATHOLOGY; PROGNOSIS; PROTECTION; SECONDARY; SEX FACTOR; SKIN TUMOR; SURVIVAL RATE;

FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROTECTIVE FACTORS; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84979784178     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000190     Document Type: Article

References (16)

1. Airtum Working Group (2011). Italian cancer figures-report 2011. Survival of cancer patients in Italy. Epidemiol Prev 5/6 (Suppl 3):102-103.
2. Crocetti E, Buzzoni C, Caldarella A, Corbinelli A, Giusti F, Intrieri T, et al. (2014). Cancer incidence in Florence (2003-2005). In: Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J, editors. Cancer incidence in five continents, vol X IARC Scientific Publication No 164. Lyon: IARC.
3. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. (2014). Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 15:23-34.
4. de Giorgi V, Mavilia C, Massi D, Gozzini A, Aragona P, Tanini A, et al. (2009). Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol 145:30-36.
5. deVries E, Nijsten TE, Visser O, Bastiaannet E, van Hattem S, Janssen-Heijnen ML, Coebergh JW (2011). Superior survival of females among 10, 538 Dutch melanoma patients is independent of Breslow thickness, histology and tumor site. Ann Melanoma Res 21:244-252.
6. Ederer F, Axtell LM, Cutler SJ (1961). The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101-121.
7. Joosse A, De Vries E, van Eijck CH, Eggermont AM, Nijsten T, Coebergh JW (2010). Reactive oxygen species and melanoma: an explanation for gender differences in survival? Pigment Cell Melanoma Res 23:352-364.
8. Joosse A, Collette S, Suciu S, Nijsten T, Lejeune F, Kleeberg UR, et al. (2012). Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol 30:2240-2247.
9. Joosse A, Collette S, Suciu S, Nijsten T, Patel PM, Keilholz U, et al. (2013). Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European Organisation for Research and Treatment of Cancer randomized controlled trials. J Clin Oncol 31:2337-2346.
10. Joosse A, van der Ploeg AP, Haydu LE, Nijsten TE, de Vries E, Scolyer RA, et al. (2015). Sex differences in melanoma survival are not related to mitotic rate of the primary tumor. Ann Surg Oncol 22:1598-1603.
11. Kemeny MM, Busch E, Stewart AK, Menck HR (1998). Superior survival of young women with malignant melanoma. Am J Surg 175:437-444.
12. Peddi P, Oh JH, Kim KB, Gershenwald JE, Palla SL, Schacherer CW, et al. (2012). Impact of comorbidities on overall survival of high-risk and advanced melanoma [abstract]. J Clin Oncol (Suppl 15):8536.
13. Percy C, Fritz A, Jack A, Shanmugarathan S, Sobin L, Parkin DM, Whelan S (2000). International Classification of Diseases for Oncology (ICD-O-3), 3rd ed. Geneva: World Health Organization.
14. Rubin DB (1976). Inference and missing data. Biometrika 63:581-592.
15. Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, et al. (2006). Gender-related differences in outcome for melanoma patients. Ann Surg 243:693-698.
16. Van Buuren S, Oudshoorn CGM (2000). Multivariate imputation by chained equations: MICE V10 User's manual TNO Report PG/VGZ/00038. Leiden: TNO Preventie en Gezondheid.